Primary Cutaneous Cryptococcosis: An Unusual Injection Site Infection

Guy Shalom1,2, Amir Horev1,3

  • 1Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

Primary cutaneous cryptococcosis (PCC) is rare, especially at injection sites in immunocompromised individuals. This case highlights treatment challenges and the critical need for proper injection site disinfection to prevent fungal infections.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Mycology

Background:

  • Primary cutaneous cryptococcosis (PCC) is an infrequent fungal infection.
  • Immunocompromised patients are at higher risk for opportunistic infections.

Observation:

  • An unusual case of PCC occurred at the injection site of an immunocompromised patient.
  • The clinical presentation posed a significant treatment dilemma.

Findings:

  • Treatment options for this PCC case presented distinct risks and benefits.
  • No single treatment was clearly superior, necessitating careful consideration.

Implications:

  • Proper disinfection of subcutaneous injection sites is crucial for preventing fungal infections.
  • Patient education on safe injection practices is vital for immunocompromised individuals.